Three Israeli start-ups raise $180m. in just 24 hours

International venture capitalists are flocking to Israel’s burgeoning hi-tech scene as a place to invest.

November 9, 2017 22:17
1 minute read.

Shekel money bills. (photo credit: REUTERS)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Three Israeli or Israeli-founded startups – Compass, Yotpo and Mitrassist – collectively raised more than $180 million in one day, a sign that international venture capitalists are flocking to Israel’s burgeoning hi-tech scene as a place to invest.

Compass, whose software introduces buyers and renters to real estate brokers, said that it raised $100m. from Fidelity Investments on Wednesday, and also from prior investors IVP and Wellington Management. To date, the company has raised $325m. since its founding four years ago.
Based in New York, Compass has a market valuation of $1.8b. and its CEO, Ori Allon, 37, owns the Hapoel Jerusalem soccer team.

Tel Aviv-based Yotpo, which allows brands to curate and respond to user-generated marketing content, announced on Twitter that it raised $51m. in the latest funding round, led by Access Industries. Since founding, the company has raised $101m., according to TheMarker.

The Biotech firm Mitrassist raised $30m. from Chinese investors. Its heart valve implant seeks to treat mitral regurgitation – a disorder resulting from the mitral valve failing to close properly while the heart is pumping out blood.

The company is receiving funds from Fosun International, a Chinese pharmaceutical company, along with the Ping An Insurance Company. Mitrassist is raising the money in two stages, the first one bringing in $16m. and an expected $14m. following the initial clinical trials. The Caesarea-based medical device company, which was founded in 2009 by Gil Naor, was valued at $80m. before this round of fund-raising.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Workers strike outside of the Teva building in Jerusalem, December 2017
December 18, 2017
Workers make explosive threats as massive Teva layoff strikes continue